4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-004499
Chief Executive Officer sold 34,435 shares at $5.08 ($174,851)
From the SEC's structured data for this filing
Trades in this filing
Brainard Diana · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-19 | Sale : show line 1 in the form | −34,435 | $5.08 | $174,851 | 601,607 | D |
| Open-market sales · 34,435 sh · avg $5.08 · $174,851 | ||||||
Loading xslF345X03/doc4.xml…